MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA, POLYGENIC HYPERCHOLESTEROLEMIA, AND THE RISK OF PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

被引：1
|
作者：
Trinder, M. [1 ]
Li, X. [1 ]
DeCastro, M. L. [1 ]
Cermakova, L. [1 ]
Sadananda, S. [2 ]
Jackson, L. [1 ]
Azizi, H. [1 ]
Mancini, G. B. J. [1 ]
Francis, G. [1 ]
Frohlich, J. [1 ]
Brunham, L. [1 ]
机构：
[1] Univ British Columbia, Ctr Heart & Lung Innovat, Vancouver, BC, Canada
[2] Indian Inst Sci Educ & Res Trivandrum, Sch Biol, Trivandrum, Kerala, India
来源：
ATHEROSCLEROSIS | 2019年 / 287卷
关键词：
D O I：
10.1016/j.atherosclerosis.2019.06.265
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS19-0070
引用
收藏
页码：E91 / E91
页数：1
相关论文
共 50 条
  • [21] Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia
    Amy L. Peterson
    Catherine J. McNeal
    Don P. Wilson
    [J]. Current Atherosclerosis Reports, 2021, 23
  • [22] Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia
    Peterson, Amy L.
    McNeal, Catherine J.
    Wilson, Don P.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (10)
  • [23] Lipoprotein (a), an additional risk factor for the occurrence of cardiovascular events in high-risk patient groups with monogenic familial hypercholesterolemia, polygenic familial hypercholesterolemia or type 2 diabetes
    del Marmol, Gregoire
    Aksel, Ysar
    Descamps, Olivier
    [J]. ACTA CARDIOLOGICA, 2020, 75 : 49 - 50
  • [24] Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
    Sharifi, Mahtab
    Higginson, Elizabeth
    Bos, Sven
    Gallivan, Angela
    Harvey, Darren
    Li, Ka Wah
    Abeysekera, Amali
    Haddon, Angela
    Ashby, Helen
    Shipman, Kate E.
    Cooper, Jackie A.
    Futema, Marta
    van Lennep, Jeanine E. Roeters
    Sijbrands, Eric J. G.
    Labib, Mourad
    Nair, Devaki
    Humphries, Steve E.
    [J]. ATHEROSCLEROSIS, 2017, 263 : 405 - 411
  • [25] MONOGENIC VERSUS POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA: GENETIC RISK SCORE AND RESPONSE TO TREATMENT
    Minicocci, I.
    D'Erasmo, L.
    Di Costanzo, A.
    Pigna, G.
    Commodari, D.
    Ceci, F.
    Montali, A.
    Maranghi, M.
    Arca, M.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E25 - E26
  • [26] Familial Hypercholesterolemia and the Atherosclerotic Disease
    Kim, Yoo Ri
    Han, Ki Hoon
    [J]. KOREAN CIRCULATION JOURNAL, 2013, 43 (06) : 363 - 367
  • [27] Distribution of lipoprotein(a) and interest of Lipoprotein(a) levels as a predictor of occurrence of cardiovascular events in monogenic familial hypercholesterolemia, polygenic familial hypercholesterolemia and diabetics patients
    Del Marmol, Gregoire
    Aksel, Ysar
    Descamps, Olivier
    [J]. ACTA CLINICA BELGICA, 2019, 74 : 22 - 22
  • [28] Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
    Lima, Isabella Ramos
    Tada, Mauricio Teruo
    Oliveira, Theo G. M.
    Jannes, Cinthia Elim
    Bensenor, Isabela
    Lotufo, Paulo A.
    Santos, Raul D.
    Krieger, Jose E.
    Pereira, Alexandre C.
    [J]. ATHEROSCLEROSIS PLUS, 2022, 49 : 47 - 55
  • [29] Polygenic Risk Scores in Familial Hypercholesterolemia
    Rader, Daniel J.
    Sheth, Samip
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (04) : 523 - 525
  • [30] LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia
    Paquette, Martine
    Bernard, Sophie
    Thanassoulis, George
    Baass, Alexis
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 627 - 633
12345